Clyra Medical Technologies, Inc. develops advanced wound management and irrigation products utilizing patent-protected oxidative chemistry. The company serves patients and healthcare providers by offering safe, non-toxic treatments designed to combat microorganisms and aid in wound healing without harming healthy tissue.
Subscribe to see Clyra Medical Technologies, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Clyra Medical Technologies, Inc. is a medical devices company headquartered in United States. Its most recent funding round raised $50,000 in January 2021. Xcout tracks 14 named people at Clyra Medical Technologies, Inc., including Steve Harrison (Chief Executive Officer).
8 more named people on record for Clyra Medical Technologies, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $50,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Clyra Medical Technologies, Inc.'s closest competitors — see the full list of competitors and alternatives →
BioWound Solutions, LLC provides advanced wound management products and dressings, including collagen technologies, antimicrobial protections, and moisture-balancing solutions. The company serves healthcare providers, clinicians, and organizations by supplying medical products designed to promote wound healing and clinical efficiency.
AOTI, Inc. (Advanced Oxygen Therapy, Inc.) develops medical devices that deliver topical oxygen therapy, including systems used to support the healing of chronic and hard-to-heal wounds. Its products are used by healthcare providers and patients in wound-care settings.
DEBx Medical develops and provides wound care products, specifically its flagship product Debrichem, designed to eliminate biofilm and infection in chronic and complex wounds. The treatment is used by healthcare professionals in ambulatory and hospital settings to facilitate faster wound bed preparation and healing while reducing the need for antibiotics and complex surgeries.
Sanara MedTech Inc. is a Fort Worth, Texas-based company established in 2001, dedicated to the development, marketing, and distribution of advanced wound and skin care products. These solutions are provided to a diverse clientele within the United States healthcare sector, including physicians, hospitals, clinics, and post-acute care facilities. The company's extensive product portfolio includes CellerateRX, a line of Surgical Activated Collagen in both powder and gel forms, designed to enhance patient healing across various surgical specialties. Sanara MedTech also offers a suite of Biako's antimicrobial products: a patented Skin and Wound Cleanser engineered to dismantle mature biofilm microbes by disrupting their extracellular polymeric substances, an Antimicrobial Wound Gel effective against both planktonic and biofilm-forming microbes, and an Antimicrobial Skin and Wound Irrigation Solution. Another key offering is HYCOL, a hydrolyzed Type I bovine collagen available as powder and gel, specifically formulated for the management of both full and partial thickness wounds, encompassing conditions such as pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. Additionally, Sanara MedTech is involved in the development of sophisticated biologic devices like FORTIFY TRG, a freeze-dried, multi-layer sheet derived from small intestinal submucosa extracellular matrix, and FORTIFY FLOWABLE extracellular matrix, an innovative wound care solution. The company also provides VIM Amnion Matrix, a single-layer amnion tissue sheet. Initially incorporated as WNDM Medical Inc., the company underwent a name change to Sanara MedTech Inc. in May 2019.
Kent Imaging develops and manufactures medical imaging devices, specifically SnapshotNIR and SnapshotGLO, which non-invasively assess tissue oxygenation and bacterial bioburden at the bedside. These portable tools provide clinicians with real-time data to evaluate wound care and reconstructive surgery patients, supporting targeted interventions and improved healing outcomes.
RenovoDerm manufactures advanced wound care products, specifically the Phoenix Wound Matrix, which is a synthetic, bioabsorbable scaffold designed to promote tissue regeneration and healing for acute and chronic wounds and burns. The company serves medical specialists such as podiatric surgeons and wound care providers by offering solutions to improve patient healing outcomes.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.